2013年国内药物经济学研究质量评价  

Quality Evaluation of Domestic Pharmacoeconomics Literatures in 2013

作　　者：孙茂[1] 冯晓远 高鹏[1] 孔彩 付希婧 朱文涛[1] 

机构地区：[1]北京中医药大学管理学院,北京100029

出　　处：《中国药房》2015年第17期2308-2311,共4页China Pharmacy

摘　　要：目的:评价2013年我国药物经济学研究质量,归纳研究中存在的主要问题。方法:检索2013年国内期刊发表的药物经济学研究文献,将相关数据提取至Excel 2013软件进行录入提取,采用QHES量表进行质量评估,并与2010年相关数据进行比较。结果:该研究共纳入文献132篇,QHES总得分为(62.90±8.50)分。药物经济学研究中存在的问题主要集中在研究角度、分析技术、贴现、敏感性分析等方面。结论:2013年药物经济学研究整体质量一般,建议加强《中国药物经济学评价指南》的推广、强化医疗机构与高校合作、期刊在文章审评环节采用QHES量表等,是提高药物经济学研究质量的有效途径。OBJECTIVE： To evaluate the quality of domestic pharmacoeconomics literatures in 2013, and summerize main prob- lems. METHODS： Pharmacoeconomics literatures published on domestic journals in 2013 were retrieved and extracted by Excel 2013. QHES was conducted to evaluate the quality and compare with the related data in 2010. RESULTS： Totally 132 literatures were includ ed with the QHES of （62.90 ± 8.50） scores. The main problems in pharmacoeconomics literatures focused on perspective, evaluation techniques, discounting and sensitivity analysis, etc. CONCLUSIONS： The overall quality of included studies in 2013 is general. It is suggested to strengthen the promotion China Guidelines for Pharmacoeconomics Evaluations and cooperation between medical institutions and universities, as well as using QHES in the review link, which is effective way to improve the quality of pharmacoeconomics literatures.

关 键 词：药物经济学 质量评价 QHES量表 

分 类 号：R956[医药卫生—药学]